In recent years, much attention has been paid to the role of PD-1/PD-L1 pathway in immune evasion within different tumor microenvironments, and PD-1/PD-L1 inhibitors have become crucial therapeutic assets against many cancers. The gene discussed is CD274; the disease is cancer.